LEMONADE INC (LMND) Stock Analyst Ratings
USA - NYSE:LMND - US52567D1072 - Common Stock
52.34 USD
+0.95 (+1.85%)
ChartMill assigns a Buy % Consensus number of 53% to LMND. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.67. This target is -10.84% below the current price.
LMND was analyzed by 16 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about LMND.
In the previous month the buy percentage consensus was at a similar level.
LMND was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-07 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-09-17 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-18 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-14 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-07-02 | BMO Capital | Maintains | Underperform -> Underperform |
| 2025-07-01 | Keefe, Bruyette & Woods | Reiterate | Underperform -> Underperform |
| 2025-04-22 | Keefe, Bruyette & Woods | Maintains | Underperform -> Underperform |
| 2025-04-08 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-02-26 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-26 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-11-21 | BMO Capital | Maintains | Underperform -> Underperform |
| 2024-11-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-11-20 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2024-11-15 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-11-07 | Keefe, Bruyette & Woods | Downgrade | Market Perform -> Underperform |
| 2024-11-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-10-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-10-09 | Jefferies | Maintains | Underperform -> Underperform |
| 2024-05-07 | Jefferies | Maintains | Underperform -> Underperform |
| 2024-05-02 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-04 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-02-29 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-02-28 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-12-01 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-11-07 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-11-02 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-10-11 | Morgan Stanley | Maintains | Underweight -> Underweight |
LEMONADE INC / LMND FAQ
What do analysts expect the price target to be for LEMONADE INC (LMND)?
16 analysts have analysed LMND and the average price target is 46.67 USD. This implies a price decrease of -10.84% is expected in the next year compared to the current price of 52.34.
Can you provide the consensus rating for LEMONADE INC stock?
The consensus rating for LEMONADE INC (LMND) is 52.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover LEMONADE INC (LMND) stock?
The number of analysts covering LEMONADE INC (LMND) is 16.